Patent · US Active

Hydroxystatin derivatives for the treatment of arthrosis

US10077288B2 · kind B2 · utility

0Cited by

4References

9Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Christos Tsaklakidis · Weinheim, DE
Markus Klein · Weiterstadt, DE

Key dates

Filing date	Nov 30, 2016
Grant date	Sep 18, 2018
Priority date	—
Expiry date	Nov 30, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of the formula (I) and in particular to medicaments comprising at least one compound of the formula (I) for use in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of arthrosis, traumatic cartilage injuries arthritis, pain, allodynia or hyperalgesia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.